Following the policy, the weekly median daily dose of publicly funded opioids began to decrease (compared with an increasing trend prepolicy), reflecting a slope change of −3.9 MME per week (95% CL, −5.5 to −2.3).
← all excerpts
Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.
1
—
—